IndraLab
Statements
Lipopolysaccharide inhibits IRF3. 25 / 25
|
25
reach
"TMED7 overexpression inhibits the ability of TRAM, an adaptor utilized by toll like receptor 4, or lipopolysaccharide to activate the interferon regulatory factor 3 signalling pathway, whereas TMED7 knockdown enhances production of the cytokine, RANTES, following lipopolysaccharide stimulation."
reach
"As previously reported, Catalpalactone can inhibit the NO synthase (iNOS) expression and the production of NO, IL6 and tumor necrosis factor-α in the lipopolysaccharide-induced macrophage, and regulate the anti-inflammatory signaling, such as inhibiting STAT-1, IFN-β and IRF3 activation, to play a cytoprotecting role [21]."